Are There Therapeutic Applications Involving Substance P?
Research into Substance P has led to the development of therapeutic applications, particularly in managing pain and inflammatory conditions. Antagonists of the neurokinin-1 receptor (NK1 receptor), which Substance P binds to, are being explored for their potential to reduce pain and inflammation. These compounds may offer new avenues for treating conditions that involve Substance P dysregulation without the adverse effects associated with conventional pain medications.
